Skip to main content
Toggle navigation
Login
Search
Home
Browse by Poster Title
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
NUM
Sort by
Title
E
Favorite
126
Effect of a Moderate CYP3A4 Inducer on the Pharmacokinetics of Omaveloxolone in Healthy Subjects
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
044
Effect of Food on the Pharmacokinetics & Safety Profile of p53 Reactivator Rezatapopt in Healthy Subjects & Patients With Solid Tumors Harboring a
TP53
Y220C Mutation
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
111
Effect of Food on the Pharmacokinetics, Safety & Tolerability of Budesonide Oral Suspension in Healthy Adults: A Randomized Phase 1 Study
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
120
Effect of Herbal Medicines on the Pharmacokinetics of Donepezil
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
037
Effect of Omaveloxolone @ Its Metabolites on Corrected QT Interval in Health Subjects
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
133
Effect of Probiotics on the Levels of Neuroendocrine Biomarkers – A Systematic Review & Meta-Analysis
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
030
Effects of Itraconazole & Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
043
Effects of the Innate Immune System, Body Habitus & Sex on the Pharmacokinetics & Antitumor Response of Anetumab Ravtansine in Patients With Solid Tumors
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
105
ENA-001, a Novel BK-channel Blocker, Enhances Hypoxic Ventilatory Sensitivity and Alleviates Propofol-induced Respiratory Effects in Healthy Volunteers
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
036
Endogenous Biomarker Use in Renal Transporter-Mediated Drug Interactions: A Literature Review of Intrinsic, Extrinsic Factors & Disease Impact on Biomarker Levels
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
A003
Enhanced HLA-B*15:02 Screening Before Carbamazepine Therapy in Vietnam: Advancements in Real-Time PCR TaqMan Probe Procedure
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
118
Evaluation of Drug-Drug Interaction in Nested Patient Studies
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
071
Evaluation of Palbociclib & Combinatorial Chemotherapy Pharmacokinetics in Pediatric Patients With Recurrent or Refractory Solid Tumors
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
011
Evaluation of Prompt Engineering Strategies for Pharmacokinetic Data Analysis With the ChatGPT Large Language Model
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
081
Exclusion of Pediatric Patients With Renal Impairment in Clinical Trials for Antiviral Products
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
084
Exploration of Estimated Renal Function & Gabapentin Clearance in Older Adults
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
079
Exploring the Impact of Hepatic Impairment on the Pharmacokinetics of New Molecular Entities: A Comprehensive Analysis of Labeling Information
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
138
Exposure-Response Analyses of Efficacy & Safety of Trastuzumab Deruxtecan to Inform Dosing Recommendation in HER2-mutant Non-Small Cell Lung Cancer
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
046
Exposure-Response Analysis to Inform QT Prolongation Potential for Cedirogant
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
